Trademarkia Logo

Canada

C$
 ICOTYDE
FORMALIZED

on 8 Jan 2025

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

2373130 filed on 8th Jan 2025

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ICOTYDE

Trademark usage description

human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary Read More

Classification Information


Class [005]
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anti-inflammatories, anti-infectives, anti-allergic medications


Classification kind code

12

Mark Details


Serial Number

2373130

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 23rd Jan 2025
Pre-Assessment Letter Sent
Submitted for opposition 30
on 8th Jan 2025
Filed
Submitted for opposition 1
on 8th Jan 2025
Created
Submitted for opposition 31
on 8th Jan 2025
Formalized